(19)
(11) EP 3 247 419 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.08.2021 Bulletin 2021/34

(45) Mention of the grant of the patent:
28.04.2021 Bulletin 2021/17

(21) Application number: 16769195.5

(22) Date of filing: 22.01.2016
(51) International Patent Classification (IPC): 
A61M 1/02(2006.01)
A61J 1/20(2006.01)
A61M 1/36(2006.01)
B01L 3/00(2006.01)
(86) International application number:
PCT/US2016/014537
(87) International publication number:
WO 2016/153590 (29.09.2016 Gazette 2016/39)

(54)

PLATELET RICH PLASMA AND BONE MARROW ASPIRATE CELL SEPARATION AND REMOVAL METHODS AND DEVICES

VERFAHREN UND VORRICHTUNGEN ZUR TRENNUNG UND ENTFERNUNG VON THROMBOZYTENREICHEM PLASMA UND KNOCHENMARKASPIRATZELLEN

MÉTHODES ET DISPOSITIFS DE SÉPARATION ET D'ÉLIMINATION DE PLASMA RICHE EN PLAQUETTES ET DE CELLULES D'ASPIRAT DE MOELLE OSSEUSE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.01.2015 EP 15152110
05.10.2015 US 201562237407 P

(43) Date of publication of application:
29.11.2017 Bulletin 2017/48

(73) Proprietors:
  • The Regents of the University of California
    Oakland, CA 94607-5200 (US)
  • The University of Southern California
    Los Angeles, CA 90089-5013 (US)

(72) Inventor:
  • EMERSON, Jane F.
    Irvine, California 92603 (US)

(74) Representative: EIP 
Fairfax House 15 Fulwood Place
London WC1V 6HU
London WC1V 6HU (GB)


(56) References cited: : 
WO-A1-2014/120797
US-A- 5 329 976
US-A1- 2006 184 103
US-A1- 2014 113 795
WO-A2-2010/077534
US-A1- 2001 055 621
US-A1- 2011 168 294
US-B2- 7 674 388
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).